Biofrontera AG — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

€30.3M

Net Income/Loss (FY2020)

-€13.0M

Total Assets (FY2020)

€56.4M

Total Equity (FY2020)

€7.4M

Cash Flows from Operating Activities (FY2020)

-€2.8M

Source: Biofrontera AG 20-F filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.